Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026

Novartis, Mesoblast ink deal worth Rs 370 crore for Remestemcel-L for Covid ARDS

Ruchika Sharma22 Nov 2020 10:30 AM IST

Zurich: Novartis aims to boost its respiratory treatment portfolio with a $50 million deal for an off-the-shelf cell therapy from Mesoblast that it...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

COVID-19 Prevention: AstraZeneca begins trials on antibody cocktail

Ruchika Sharma22 Nov 2020 9:30 AM IST

London: AstraZeneca started late-stage trials on Saturday of an experimental long-acting monoclonal antibody combination drug it hopes could be...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Covid-19: Saudi Arabia commits over Rs 3708 crore to vaccine development

Ruchika Sharma22 Nov 2020 9:00 AM IST

Riyadh: The Saudi Arabian government has committed more than $500 million to funding efforts to develop and produce a safe and effective vaccine...

Baby Powder Case: Johnson and Johnson directed to pay over Rs 889 crore for damages in NY

Ruchika Sharma21 Nov 2020 3:29 PM IST

Justice Gerald Lebovits of the state supreme court in Manhattan reduced the payout from the USD 325 million that a jury awarded Donna Olson, 67, and...

Gilead remdesivir suspended by WHO from prequalification list of COVID-19 drugs

Ruchika Sharma21 Nov 2020 1:41 PM IST

New Delhi: The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official...

Russia resumes Covid vaccine trial after pause

Ruchika Sharma21 Nov 2020 11:51 AM IST

Moscow: Russia has resumed the vaccination of new volunteers in its trial for its flagship Covid-19 Sputnik V vaccine after a short pause, staff at...

Syngene inks 5 year strategic collaboration with Deerfield Discovery and Development

Ruchika Sharma21 Nov 2020 11:00 AM IST

Bengaluru: Syngene International and Deerfield Discovery and Development Corporation (3DC), the drug discovery and development subsidiary of Deerfield...

Indias generic drugs safe as Trump targets branded pharma imports: Experts

Trump alleges big pharma firms ran millions of dollars of negative ad against him during election campaign

Ruchika Sharma21 Nov 2020 9:00 AM IST

Washington: US President Donald Trump on Friday alleged that big pharma companies ran millions of dollars of negative advertisement against him during...

Covishield to be priced at Rs 1000 for 2 necessary doses for public, says Serum CEO

Ruchika Sharma20 Nov 2020 12:30 PM IST

Poonawalla said the Oxford vaccine is affordable, safe and stored at a temperature of two to eight degrees Celsius, which is an ideal temperature for...

AstraZeneca, Oxford COVID vaccine shows promise, trial results by December

Ruchika Sharma20 Nov 2020 12:00 PM IST

London: AstraZeneca and Oxford University's potential Covid-19 vaccine produced a strong immune response in older adults, data published on Thursday...

Microsoft, Social Alpha join hands for healthtech startups in India

Ruchika Sharma20 Nov 2020 11:30 AM IST

New Delhi: Microsoft has launched a dedicated program for healthtech startups. The program is designed to help startups scale with advanced...

Sinovac COVID-19 vaccine CoronaVac induces quick immune response: study

Ruchika Sharma20 Nov 2020 9:00 AM IST

Singapore/Beijing: Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok